Separate terms with OR to return results that match either term.
 
Clear All
10,000 Matching Results — Export these results
Click column titles once to sort ascending, and twice to sort descending.
Show Entries
NDC-11 (Package) (Descending) NDC-9 (Product) Generic Name Brand Name Strength SEER*Rx Category Major Class Minor Class Administration Route Package Effective Date Package Discontinuation Date Status
00527-1779-14 00527-1779 Temozolomide Temozolomide 100.0 mg/1 Chemotherapy Alkylating Agent Tetrazine Oral March 23, 2016 May 24, 2018 In Use
00527-1778-55 00527-1778 Temozolomide Temozolomide 20.0 mg/1 Chemotherapy Alkylating Agent Tetrazine Oral March 23, 2016 May 24, 2018 In Use
00527-1778-14 00527-1778 Temozolomide Temozolomide 20.0 mg/1 Chemotherapy Alkylating Agent Tetrazine Oral March 23, 2016 May 24, 2018 In Use
00527-1777-55 00527-1777 Temozolomide Temozolomide 5.0 mg/1 Chemotherapy Alkylating Agent Tetrazine Oral March 23, 2016 May 24, 2018 In Use
00527-1777-14 00527-1777 Temozolomide Temozolomide 5.0 mg/1 Chemotherapy Alkylating Agent Tetrazine Oral March 23, 2016 May 24, 2018 In Use
00527-1726-41 00527-1726 Ondansetron Hydrochloride Ondansetron Hydrochloride 2.0 mg/mL Ancillary Therapy Antiemetic 5HT3 Receptor Antagonist Intramuscular, Intravenous July 1, 2010 In Use
00527-1726-40 00527-1726 Ondansetron Hydrochloride Ondansetron Hydrochloride 2.0 mg/mL Ancillary Therapy Antiemetic 5HT3 Receptor Antagonist Intramuscular, Intravenous July 1, 2010 In Use
00527-1712-30 00527-1712 Letrozole Letrozole 2.5 mg/1 Hormonal Therapy Aromatase Inhibitor Oral Oct. 29, 2014 June 16, 2017 No Longer Used
00527-1452-06 00527-1452 Dronabinol Dronabinol 10.0 mg/1 Ancillary Therapy Antiemetic CB1/CB2 Oral May 18, 2018 In Use
00527-1451-06 00527-1451 Dronabinol Dronabinol 5.0 mg/1 Ancillary Therapy Antiemetic CB1/CB2 Oral May 18, 2018 In Use
00527-1450-06 00527-1450 Dronabinol Dronabinol 2.5 mg/1 Ancillary Therapy Antiemetic CB1/CB2 Oral May 18, 2018 In Use
00527-1242-02 00527-1242 Fludarabine Phosphate Fludarabine Phosphate 25.0 mg/mL Chemotherapy Antimetabolite Purine Analog Intravenous Dec. 31, 2019 In Use
00517-4930-25 00517-4930 Dexamethasone Sodium Phosphate Dexamethasone Sodium Phosphate 4.0 mg/mL, 4.0 mg/mL Hormonal Therapy Adrenal Glucocorticoid Corticosteroid Intra-Articular, Intra-articular, Intralesional, IM, IV, Intralesional, Intramuscular, Intravenous, Soft Tissue Sept. 30, 1990 Nov. 8, 2016 No Longer Used
00517-4905-25 00517-4905 Dexamethasone Sodium Phosphate Dexamethasone Sodium Phosphate 4.0 mg/mL, 4.0 mg/mL Hormonal Therapy Adrenal Glucocorticoid Corticosteroid Intra-Articular, Intra-articular, Intralesional, IM, IV, Intralesional, Intramuscular, Intravenous, Soft Tissue Sept. 30, 1990 Nov. 8, 2016 No Longer Used
00517-4901-25 00517-4901 Dexamethasone Sodium Phosphate Dexamethasone Sodium Phosphate 4.0 mg/mL, 4.0 mg/mL Hormonal Therapy Adrenal Glucocorticoid Corticosteroid Intra-Articular, Intra-articular, Intralesional, IM, IV, Intralesional, Intramuscular, Intravenous, Soft Tissue Sept. 30, 1990 Nov. 8, 2016 No Longer Used
00517-4300-01 00517-4300 Paclitaxel PACLITAXEL PROTEIN BOUND PARTICLES ALBUMIN BOUND 100.0 mg/20mL Chemotherapy Antimitotic Agent Taxane Intravenous May 2, 2023 In Use
00517-0920-08 00517-0920 Busulfan Busulfan 6.0 mg/mL Chemotherapy Alkylating Agent Alkylsulfonate Intravenous April 1, 2017 In Use
00517-0746-01 00517-0746 Pamidronate Disodium Pamidronate Disodium 9.0 mg/mL Ancillary Therapy Bisphosphonate Intravenous Aug. 9, 2010 Nov. 1, 2012 No Longer Used
00517-0745-01 00517-0745 Pamidronate Disodium Pamidronate Disodium 3.0 mg/mL Ancillary Therapy Bisphosphonate Intravenous July 16, 2010 Aug. 24, 2012 No Longer Used
00517-0440-01 00517-0440 ESTRADIOL VALERATE ESTRADIOL VALERATE 40.0 mg/mL Hormonal Therapy Estrogen Intramuscular March 1, 2020 In Use
00517-0420-01 00517-0420 ESTRADIOL VALERATE ESTRADIOL VALERATE 20.0 mg/mL Hormonal Therapy Estrogen Intramuscular March 1, 2020 In Use
00480-9772-01 00480-9772 Fludarabine Phosphate Fludarabine Phosphate 25.0 mg/mL Chemotherapy Antimetabolite Purine Analog Intravenous Aug. 31, 2023 In Use
00480-5425-89 00480-5425 Sorafenib Sorafenib 200.0 mg/1 Chemotherapy Tyrosine Kinase Inhibitor VEGFR, FLT, PDGFR, KIT, RET, RET/PTC, CRAF, BRAF Oral Jan. 3, 2023 In Use
00480-4516-01 00480-4516 Pemetrexed Pemetrexed 25.0 mg/mL Chemotherapy Antimetabolite Folic Acid Analog Intravenous June 1, 2022 In Use
00480-4515-01 00480-4515 Pemetrexed Pemetrexed 25.0 mg/mL Chemotherapy Antimetabolite Folic Acid Analog Intravenous May 31, 2022 In Use

Found 10,000 results in 9 milliseconds — Export these results